Why the study?
Does statin therapy reduce mid-term all-cause mortality rate in patients after TAVI?
Does statin therapy reduce mid-term all-cause mortality rate in patients after TAVI?
Statin therapy may reduce mid-term all-cause mortality following TAVI, though current evidence is limited to observational studies.
Answers are grounded in this paper and cite their sources.
May support statin use post-TAVI; leaves open confirmation in randomized trials before practice change.
= .0). Statin therapy could reduce the mid-term all-cause mortality rate following TAVI. However, all included studies were observational and, therefore, randomized controlled trials are still needed to assess the effect of statin therapy on mortality after TAVI.
No takes yet. Share an insight, caveat, or question.
Yarahmadi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: